Filing Flows › Onconetix (ONCO) › Q2 2025
Onconetix (ONCO) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Onconetix (ONCO) reported revenue of $106K for the second quarter 2025 (Q2 2025), -85% from a year earlier and +5% from the quarter before.
Onconetix, Q2 2025: revenue $106K (-85% year over year), net loss $2.4M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $106K | +5% | -85% |
| Operating profit | −$1.9M | — | — |
| Net earnings | −$2.4M | — | — |
| Operating cash flow | −$1.4M | — | — |
What changed
Revenue was $106K in Q2 2025, down 85% year over year and up 5% from the previous quarter.
Gross margin was 66.2%, up 51.9 points from a year earlier. Operating costs exceeded revenue by $1.9M, an operating margin of -1817.4%. Operating expenses fell 85% while revenue fell 85%. The quarter ended with a net loss of $2.4M, narrower than the previous quarter's $8.5M loss.
Operating cash flow was −$1.4M. Non-cash charges added back $4K of depreciation and amortization and $31K of share-based compensation. Working capital and other items added $927K.
Questions
What was Onconetix's revenue in the second quarter 2025?
Onconetix (ONCO) reported revenue of $106K for the second quarter 2025 (Q2 2025), -85% from a year earlier and +5% from the quarter before.
Source: Onconetix 10-Q on SEC EDGAR.